Royalty Pharma PLC Class A RPRX
News
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference
Royalty Pharma Reports Second Quarter 2024 Results
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024
Royalty Pharma Declares Third Quarter 2024 Dividend
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion